Treatment of childhood Plasmodium falciparum malaria: current challenges
- PMID: 17266461
- DOI: 10.1586/14787210.5.1.141
Treatment of childhood Plasmodium falciparum malaria: current challenges
Abstract
Malaria continues to be a major cause of mortality and morbidity in tropical countries. Infection with Plasmodium falciparum may be asymptomatic, cause an uncomplicated febrile illness or give rise to severe disease complicated by coma, acidosis or severe anemia. Treatment of the febrile illness with two drugs--preferably in the form of an artemisinin-containing combination therapy--is now widely recommended, both for greater efficacy and in order to delay the evolution of drug resistance. The clinical picture of severe malaria differs according to the age and immune status of the individual; treatment requires a range of supportive measures, as well as an efficacious antimalarial drug. Insecticide-treated bednets and presumptive treatment programs are increasingly deployed in malaria control programs, while vaccines are showing promise.
Similar articles
-
Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.Am J Trop Med Hyg. 2007 Nov;77(5):947-54. Am J Trop Med Hyg. 2007. PMID: 17984359 Clinical Trial.
-
Artemisinin derivatives and malaria: useful, in combination with other antimalarials.Prescrire Int. 2008 Aug;17(96):162-8. Prescrire Int. 2008. PMID: 19492494
-
[Beneficial effect of using ACT for treatment of uncomplicated falciparum malaria on prevention of severe malarial anemia in children].Med Trop (Mars). 2008 Oct;68(5):545-8. Med Trop (Mars). 2008. PMID: 19068993 French.
-
Helicases - feasible antimalarial drug target for Plasmodium falciparum.FEBS J. 2007 Sep;274(18):4699-704. doi: 10.1111/j.1742-4658.2007.06000.x. FEBS J. 2007. PMID: 17824956 Review.
-
Drug resistant falciparum malaria: clinical consequences and strategies for prevention.Drug Resist Updat. 2001 Jun;4(3):187-96. doi: 10.1054/drup.2001.0195. Drug Resist Updat. 2001. PMID: 11768332 Review.
Cited by
-
Prevalence of malaria and Schistosoma mansoni coinfection in sub Saharan Africa: A systematic review and meta-analysis.Parasite Epidemiol Control. 2025 Mar 13;29:e00422. doi: 10.1016/j.parepi.2025.e00422. eCollection 2025 May. Parasite Epidemiol Control. 2025. PMID: 40166801 Free PMC article. Review.
-
Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial.Clin Infect Dis. 2012 Apr;54(8):1080-90. doi: 10.1093/cid/cis034. Epub 2012 Mar 12. Clin Infect Dis. 2012. PMID: 22412067 Free PMC article. Clinical Trial.
-
The antimalarial drug quinine disrupts Tat2p-mediated tryptophan transport and causes tryptophan starvation.J Biol Chem. 2009 Jul 3;284(27):17968-74. doi: 10.1074/jbc.M109.005843. Epub 2009 May 5. J Biol Chem. 2009. PMID: 19416971 Free PMC article.
-
Assessing Asymptomatic Malaria Carriage of Plasmodium falciparum and Non-falciparum Species in Children Resident in Nkolbisson, Yaoundé, Cameroon.Children (Basel). 2021 Oct 24;8(11):960. doi: 10.3390/children8110960. Children (Basel). 2021. PMID: 34828673 Free PMC article.
-
Severe malaria and death risk factors among children under 5 years at Jason Sendwe Hospital in Democratic Republic of Congo.Pan Afr Med J. 2018 Apr 2;29:184. doi: 10.11604/pamj.2018.29.184.15235. eCollection 2018. Pan Afr Med J. 2018. PMID: 30061962 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources